C12N 2760/12122
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/12122 (New viral proteins or individual genes, new structural or functional aspects of) appears on 23 US grants and 19 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 19
- Assignees
- 18
- Inventors
- 38
- Latest grant
- 15 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 2 |
| 2012 | 1 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 3 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 2 | 0 |
| 2020 | 0 | 1 |
| 2021 | 2 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Stabilized recombinant hantaviral spike proteins comprising mutations in Gc15 Aug 2023US 11,723,968 B2FundacióN Ciencia Para La Vida
- Sin Nombre virus full-length M segment-based DNA vaccines26 Oct 2021US 11,155,834 B2The Government of the United States, as represented by the Secretary of the Army
- Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses30 Mar 2021US 10,961,279 B2ISD Immunotech ApS
- Gene optimized Hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome3 Dec 2019US 10,493,142 B2
- Sin Nombre virus full-length M segment-based DNA vaccines15 Oct 2019US 10,443,073 B2The Government of the United States, as represented by the Secretary of the Army
- Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses9 May 2024US 2024/0150409 A1ISD Immunotech ApS
- Sin nombre virus full-length m segment-based dna vaccines24 Mar 2022US 2022/0090136 A1The Government of the United States, as represented by the Secretary of the Army
- Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses8 Jul 2021US 2021/0206812 A1ISD Immunotech ApS
- Engineered spike proteins of hantaviruses and uses thereof7 Jan 2021US 2021/0000940 A1FundacióN Ciencia Para La Vida
- Sin nombre virus full-length m segment-based dna vaccines2 Apr 2020US 2020/0102576 A1The Government of the United States, as represented by the Secretary of the Army
Most cited
By later US patents
- NYVAC vaccinia virus recombinants comprising heterologous inserts137US 5,494,807 AVirogenetics Corporation · 1996
- Modified recombinant vaccinia virus and expression vectors thereof65US 5,762,938 AVirogenetics Corporation · 1998
- Alvac canarypox virus recombinants comprising heterlogous inserts56US 5,756,103 AVirogenetics Corporation · 1998
- Trova fowl pox virus recombinants comprising heterologous inserts16US 5,766,599 AVirogenetics Corporation · 1998
- Strain of hantavirus nucleotide sequences thereof related probes, primers and vectors, and methods for detection7US 5,945,277 AThe United States of America as represented by the Department of Health and Human Services · 1999